55]) and polymorphic VPB .05]) were independantly associated with CM compared to controls (p<0.05).
Introduction: early repolarization (ER) in Brugada or short QT syndrome is common and has been associated with a less favourable outcome. Even if apparently paradoxical, ER can also be seen in long QT (LQT) but prevalence and correlations to other variables are unknown.
Methods: ECG of 105 LQT patients (44 men, 36±21 yo) and 269 age and gender matched controls (135 men, 36±18 yo) were reviewed. LQT was diagnosed by a positive genetic testing (n=71) or by showing abnormal T wave and long QT interval spontaneously or during epinephrin infusion in pts without discovered genetic mutation (n=34). ER was defined by > 1mm J point elevation in the inferior or lateral leads with notch or slurring pattern.
Results: QT in lead II was 433±68 msec in LQT patients and 338±41 in controls (p<0.0001) (QTc 446±52 versus 377±30 msec, p<0.0001). Heart rate wq lower in LQT patients (66±14 vs 79±19 bpm) (p<0.0001). Twenty LQT patients presented with resuscitated sudden death or torsades de pointes and 11 with syncope. 33/105 LQT patients (31%) had ER compared to 31/269 (12%) controls (p<0.0001).
ER was more frequent in LQT men (19/44, 43%) compared to women (14/61, 23%) (p=0.03) but was not correlated to age (41±20 yo with ER vs 35±21 bpm, p=0.17).
LQT patients with ER had lower heart rates (61±11 vs 69±15 bpm, p=0.02).
There was a trend toward longer QT in patients with ER (449±73 versus 426±64 msec in lead II, p=0.1) but not for corrected QT intervals (442±48 versus 448±54 msec, p=0.5).
There was more frequent ER in case of HeRG (14/26) than KCNQ1 (6/34) or KCNJ2 (2/10) mutations (p=0.008).
ER in LQT patients was not correlated to symptoms or cardiac events (5/20 patients with SD, 3/11 in patients with syncope and 25/72 asymptomatic LQT) (p=0.6).
Conclusion: ER is very common in LQT patients and is related to the gender and to the heart rate but not to age or to the corrected QT duration. ER is not correlated to cardiac events in this series but may is to HeRG mutations
Arrhythmic risk stratification and prognostic value of programmed ventricular stimulation in arrhythmogenic right ventricular cardiomyopathy/dysplasia
Carole Maupain, Nicolas Badenco, Guillaume Duthoit, Xavier Waintraub, Thomas Chastre, Caroline Himbert, Françoise Hidden-Lucet, Estelle Gandjbakhch CHU La Pitié-Salpétrière-APHP, Institut de Cardiologie, Paris, France Background: The role of programmed ventricular stimulation (PVS) in arrhythmic risk stratification is unclear in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D).
Objective:
To determine clinical factors associated with inducibility of PVS and determine its pronostic value in the overall population and in three risk groups.
Methods: Between 2000 and 2010, 150 consecutive patients systematically benefited PVS at diagnosis. Predictors for PVS inducibility were studied. Risk factors for arrhythmic events were then determined by Cox regression in the entire population and in three risk groups.
Results: VT inducibility was significantly higher for males (p=0.007), symptomatic patients (p<0.001) especially those with syncope (p=0.004), patients who had spontaneous ventricular tachycardia (VT) (p<0.001) and right (p<0.001) or left (p=0.03) ventricular dysfunction.
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After a follow up of 48±32 months, we recorded 31 ventricular arrhythmias and 10 sudden cardiac deaths (SCD). Male gender, symptoms, syncope, sustained VT, right or left ventricular dysfunction and positive PVS were associated with ventricular arrhythmias. PVS had a 50% of sensibility on predicting SCD. The presence of a history of an aborted SCD, syncope or non tolerated VT identified high-risk subjects whereas asymptomatic patients represented a low risk group whatever PVS results were. Inducibility at PVS was associated with a higher rate of events in the intermediate risk group. A decision tree based on our analyses is shown on figure 1 above.
Conclusion:
PVS inducibility is associated with the occurrence of sustained ventricular arrythmia but not with the occurrence of SCD. History of aborted SCD, syncope or non tolerated VT isolate a high risk group of patients whereas asymptomatic patients are at low risk. PVS seems to be interesting in the intermediate risk group for predicting ventricular arrhythmias.
Clinical interest of transesophageal electrophysiological study in patients with no documented tachycardia suspected of paroxysmal supraventricular tachycardia
Béatrice Brembilla-Perrot (1), Jean Marc Sellal (1), Arnaud Olivier (1), Vladimir Manenti (1), Nicolas Girerd (2), Joseph Rizk (1), Thibaut Villemin (1), Anne Moulin-Zinsch (3) (1) CHU Nancy Brabois, Cardiologie, Vandoeuvre Les Nancy, France -(2) INSERM, Centre d'Investigations Cliniques 9501, Vandoeuvre Les Nancy, France -(3) CHU Nancy Brabois, Cardiologie pédiatrique, Vandoeuvre Les Nancy, France Paroxysmal supraventricular tachycardia (SVT) documentation is not always easy and in some patients referred for SVT ablation, EPS sometimes remains negative. The purpose of study was to evaluate the follow-up after esophageal EPS for no documented tachycardia.
Methods: 1569 patients, mean age 42±19.5 years, 637 males, with normal ECG in sinus rhythm, were suspected of SVT. Exercise testing, 24 hour Holter monitoring were normal. Transesophageal EPS consisted of programmed stimulation with 1 and 2 extrastimuli in control state and after isoproterenol.
Results: EPS remained negative in 594 patients (group I). Atrial fibrillation/tachycardia (AF) was induced in 70 patients (group II), atrioventricular (AV) nodal reentrant tachycardia (AVNRT) or AVRT using a concealed accessory pathway in 887 patients (group III). Group I was younger (34± 17 years) than group II (53±16), III (46±20)(p<0.001). Group II was older than group III (p<0.001). Group I was more frequently of female gender (62%) than group II (56.5%)(no difference with group II)(67%). Group I had more frequently associated dizziness/syncope (41%) or chest pain (22%) than group II (20, 5%) or III (19, 6%)(p<0.001). Associated moderate heart disease was more frequent in group II (15%) than in group I (4.5%)(p<0.001) or III (8%)(p<0.003). During follow-up (mean 5±4 years), tachycardia was documented in 21 group I patients (3.5%)(AF 11, AVNRT/AVRT 8, ventricular tachycardia 1), 18 group II patients (20%)(p<0.0001)(AF), 370 group III patients (42%)(p<0.0001)(AVNRT/AVRT 361, AF 9). 2 group II patients (3%), 13 group III patients (7%) died (p<0.003). Ablation (AF or AVNRT/ AVRT) was performed in 8 group I patients (1%), 10 group II patients (11%)(p<0.001), 348 group III patients (39%)(p<0.0001).
Conclusions:
Prognosis value esophageal EPS was excellent. A negative study noted in younger patients complaining frequently of dizziness/syncope/ chest pain predicted a favorable prognosis. None of the patients with induced AF had AVNRT/AVRT and this group (older, with HD) had frequently AF during follow-up (20%). Patients with induced AVNRT/AVRT benefit frequently from ablation of their tachycardia.
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